{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:18:14Z","timestamp":1787167094475,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":2385,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular &amp; Cellular Proteomics"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1074\/mcp.m113.030775","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T21:11:25Z","timestamp":1387573885000},"page":"701-715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma"],"prefix":"10.1016","volume":"13","author":[{"given":"Filip","family":"Mundt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik J.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Forshed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serta\u00e7","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Metintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Dobra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Lehti\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hjerpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.M113.030775_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/JCO.1988.6.1.147","article-title":"Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965\u20131985","volume":"6","author":"Antman","year":"1988","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.M113.030775_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1440-1843.2005.00714.x","article-title":"Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma","volume":"10","author":"Sterman","year":"2005","journal-title":"Respirology"},{"key":"10.1074\/mcp.M113.030775_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M113.030775_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/JTO.0b013e318180477b","article-title":"Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma","volume":"3","author":"Creaney","year":"2008","journal-title":"J. Thorac. Oncol"},{"key":"10.1074\/mcp.M113.030775_bib5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1164\/rccm.200511-1789OC","article-title":"Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma","volume":"173","author":"Scherpereel","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1074\/mcp.M113.030775_bib6","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.1074\/mcp.M113.030775_bib7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.clinbiochem.2009.03.007","article-title":"Serum mesothelin has a higher diagnostic utility than hyaluronic acid in malignant mesothelioma","volume":"42","author":"Grigoriu","year":"2009","journal-title":"Clin. Biochem"},{"key":"10.1074\/mcp.M113.030775_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2011.02.007","article-title":"Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma\u2014which is best?","volume":"74","author":"Creaney","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1074\/mcp.M113.030775_bib9","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-06-0472","article-title":"Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma","volume":"12","author":"Onda","year":"2006","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M113.030775_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1349-7006.2006.00246.x","article-title":"Novel ELISA system for detection of N-ERC\/mesothelin in the sera of mesothelioma patients","volume":"97","author":"Shiomi","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1074\/mcp.M113.030775_bib11","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1073\/pnas.96.20.11531","article-title":"Soluble member(s) of the mesothelin\/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma","volume":"96","author":"Scholler","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M113.030775_bib12","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M113.030775_bib13","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1373\/clinchem.2008.121913","article-title":"Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum","volume":"55","author":"Hollevoet","year":"2009","journal-title":"Clin. Chem"},{"key":"10.1074\/mcp.M113.030775_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1378\/chest.11-0129","article-title":"The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor","volume":"141","author":"Hollevoet","year":"2011","journal-title":"Chest"},{"key":"10.1074\/mcp.M113.030775_bib15","first-page":"1427","article-title":"Impact of renal failure on the tumor markers of mesothelioma, N-ERC\/mesothelin and osteopontin","volume":"31","author":"Shiomi","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1074\/mcp.M113.030775_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0021-9258(18)73363-2","article-title":"Hyaluronic acid in the pleural fluid associated with a malignant tumor involving the pleura and peritoneum","volume":"133","author":"Meyer","year":"1940","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M113.030775_bib17","first-page":"47","article-title":"Hyaluronic acid in the pleural and peritoneal fluids from a case of mesothelioma","volume":"56","author":"Blix","year":"1951","journal-title":"Acta Soc. Med. Ups"},{"key":"10.1074\/mcp.M113.030775_bib18","first-page":"81","article-title":"The detection of hyaluronic acid in pleural fluids of cases with diffuse pleural mesotheliomas","volume":"44","author":"Harington","year":"1963","journal-title":"Br. J. Exp. Pathol"},{"key":"10.1074\/mcp.M113.030775_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0009-8981(77)90162-0","article-title":"Acid glycosaminoglycans (mucopolysaccharides) in the differential diagnosis of pleural effusion","volume":"76","author":"Friman","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/mcp.M113.030775_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0009-8981(71)90505-5","article-title":"[Detection and estimation of hyaluronic acid in the pleural fluid of mesothelioma]","volume":"33","author":"Havez","year":"1971","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/mcp.M113.030775_bib21","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/clinchem\/32.6.952","article-title":"Liquid-chromatographic determination of hyaluronic acid in pleural and ascitic fluids","volume":"32","author":"Hjerpe","year":"1986","journal-title":"Clin. Chem"},{"key":"10.1074\/mcp.M113.030775_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/clinchem\/40.5.777","article-title":"Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content","volume":"40","author":"Nurminen","year":"1994","journal-title":"Clin. Chem"},{"key":"10.1074\/mcp.M113.030775_bib23","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/1097-0142(19940301)73:5<1406::AID-CNCR2820730515>3.0.CO;2-I","article-title":"The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods","volume":"73","author":"Martensson","year":"1994","journal-title":"Cancer"},{"key":"10.1074\/mcp.M113.030775_bib24","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1183\/09031936.97.10020404","article-title":"Immunohistochemical differences between hyaluronan- and non-hyaluronan-producing malignant mesothelioma","volume":"10","author":"Thylen","year":"1997","journal-title":"Eur. Resp. J"},{"key":"10.1074\/mcp.M113.030775_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00428-007-0375-x","article-title":"Cytological diagnosis of malignant mesothelioma\u2014improvement by additional analysis of hyaluronic acid in pleural effusions","volume":"450","author":"Welker","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1074\/mcp.M113.030775_bib26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1158\/1078-0432.CCR-0607-3","article-title":"Gene expression profiles predict survival and progression of pleural mesothelioma","volume":"10","author":"Pass","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M113.030775_bib27","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMoa051185","article-title":"Asbestos exposure, pleural mesothelioma, and serum osteopontin levels","volume":"353","author":"Pass","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/mcp.M113.030775_bib28","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-06-2144","article-title":"Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment","volume":"13","author":"Grigoriu","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M113.030775_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/172460080902400208","article-title":"Osteopontin is not a specific marker in malignant pleural mesothelioma","volume":"24","author":"Paleari","year":"2009","journal-title":"Int. J. Biol. Markers"},{"key":"10.1074\/mcp.M113.030775_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/153303460900800502","article-title":"Protein profiling of pleural effusions to identify malignant pleural mesothelioma using SELDI-TOF MS","volume":"8","author":"Hegmans","year":"2009","journal-title":"Technol. Cancer Res. Treat"},{"key":"10.1074\/mcp.M113.030775_bib31","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1115050","article-title":"Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma","volume":"367","author":"Pass","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/mcp.M113.030775_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nmeth.1322","article-title":"Universal sample preparation method for proteome analysis","volume":"6","author":"Wisniewski","year":"2009","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.M113.030775_bib33","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1002\/pmic.200800174","article-title":"Quantitative membrane proteomics applying narrow range peptide isoelectric focusing for studies of small cell lung cancer resistance mechanisms","volume":"8","author":"Eriksson","year":"2008","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M113.030775_bib34","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1002\/pmic.200600782","article-title":"iTRAQ compatibility of peptide immobilized pH gradient isoelectric focusing","volume":"7","author":"Lengqvist","year":"2007","journal-title":"Proteomics"},{"key":"10.1074\/mcp.M113.030775_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nmeth.2732","article-title":"HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics","volume":"11","author":"Branca","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.M113.030775_bib36","doi-asserted-by":"crossref","first-page":"D1063","DOI":"10.1093\/nar\/gks1262","article-title":"The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013","volume":"41","author":"Vizcaino","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.M113.030775_bib37","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/mcp.M113.030775_bib38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1471-2164-9-488","article-title":"BioVenn\u2014a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams","volume":"9","author":"Hulsen","year":"2008","journal-title":"BMC Genomics"},{"key":"10.1074\/mcp.M113.030775_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc"},{"key":"10.1074\/mcp.M113.030775_bib40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1471-2105-9-265","article-title":"StAR: a simple tool for the statistical comparison of ROC curves","volume":"9","author":"Vergara","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1074\/mcp.M113.030775_bib41","doi-asserted-by":"crossref","first-page":"e72030","DOI":"10.1371\/journal.pone.0072030","article-title":"Hyaluronan and N-ERC\/mesothelin as key biomarkers in a specific two-step model to predict pleural malignant mesothelioma","volume":"8","author":"Mundt","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/mcp.M113.030775_bib42","doi-asserted-by":"crossref","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/mcp.M113.030775_bib43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2012","journal-title":"Arch. Pathol. Lab. Med"},{"key":"10.1074\/mcp.M113.030775_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1074\/mcp.M113.030775_bib45","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2011.104","article-title":"Markers for the non-invasive diagnosis of mesothelioma: a systematic review","volume":"104","author":"van der Bij","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1074\/mcp.M113.030775_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PAT.0b013e3283445e67","article-title":"Molecular biomarkers in malignant mesothelioma: state of the art","volume":"43","author":"Kao","year":"2011","journal-title":"Pathology"},{"key":"10.1074\/mcp.M113.030775_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1165\/rcmb.2009-0206TR","article-title":"Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways","volume":"42","author":"Heintz","year":"2010","journal-title":"Am. J. Respir. Cell. Mol. Biol"},{"key":"10.1074\/mcp.M113.030775_bib48","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M112.016998","article-title":"Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes","volume":"11","author":"Sandberg","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.M113.030775_bib49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1440-1843.2005.00694.x","article-title":"Pathogenesis of malignant pleural mesothelioma","volume":"10","author":"Jaurand","year":"2005","journal-title":"Respirology"},{"key":"10.1074\/mcp.M113.030775_bib50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.addr.2009.01.001","article-title":"Catalase delivery for inhibiting ROS-mediated tissue injury and tumor metastasis","volume":"61","author":"Nishikawa","year":"2009","journal-title":"Adv. Drug Deliv. Rev"},{"key":"10.1074\/mcp.M113.030775_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2407-10-245","article-title":"Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin","volume":"10","author":"Shiau","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1074\/mcp.M113.030775_bib52","doi-asserted-by":"crossref","first-page":"e46091","DOI":"10.1371\/journal.pone.0046091","article-title":"Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool","volume":"7","author":"Ostroff","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/mcp.M113.030775_bib53","doi-asserted-by":"crossref","first-page":"351089","DOI":"10.1155\/2012\/351089","article-title":"Matricellular proteins: a sticky affair with cancers","volume":"2012","author":"Chong","year":"2012","journal-title":"J. Oncol"},{"key":"10.1074\/mcp.M113.030775_bib54","first-page":"5334","article-title":"Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor","volume":"56","author":"Zanella","year":"1996","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M113.030775_bib55","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1007\/s00018-010-0395-6","article-title":"The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells","volume":"67","author":"Cermak","year":"2010","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1074\/mcp.M113.030775_bib56","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/pr1008724","article-title":"Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling","volume":"10","author":"Chiu","year":"2011","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.M113.030775_bib57","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1745-7270.2008.00392.x","article-title":"High expression of osteoglycin decreases the metastatic capability of mouse hepatocarcinoma Hca-F cells to lymph nodes","volume":"40","author":"Cui","year":"2008","journal-title":"Acta Biochim. Biophys. Sin"},{"key":"10.1074\/mcp.M113.030775_bib58","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.3748\/wjg.15.6117","article-title":"High expression of osteoglycin decreases gelatinase activity of murine hepatocarcinoma Hca-F cells","volume":"15","author":"Cui","year":"2009","journal-title":"World J. Gastroenterol"},{"key":"10.1074\/mcp.M113.030775_bib59","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1593\/neo.11446","article-title":"Pigment epithelium-derived factor blocks tumor extravasation by suppressing amoeboid morphology and mesenchymal proteolysis","volume":"13","author":"Ladhani","year":"2011","journal-title":"Neoplasia"},{"key":"10.1074\/mcp.M113.030775_bib60","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.athoracsur.2004.03.021","article-title":"Effect of inhibition of multiple steps of angiogenesis in syngeneic murine pleural mesothelioma","volume":"78","author":"Merritt","year":"2004","journal-title":"Ann. Thorac. Surg"},{"key":"10.1074\/mcp.M113.030775_bib61","doi-asserted-by":"crossref","first-page":"137R","DOI":"10.1093\/glycob\/cwl025","article-title":"Galectin-1: a small protein with major functions","volume":"16","author":"Camby","year":"2006","journal-title":"Glycobiology"},{"key":"10.1074\/mcp.M113.030775_bib62","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1074\/jbc.M111.321190","article-title":"Lung cancer-derived galectin-1 enhances tumorigenic potentiation of tumor-associated dendritic cells by expressing heparin-binding EGF-like growth factor","volume":"287","author":"Kuo","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M113.030775_bib63","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/carcin\/bgt040","article-title":"Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin alpha6beta4 and Notch1\/Jagged2 signaling pathway","volume":"34","author":"Hsu","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1074\/mcp.M113.030775_bib64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000087841","article-title":"Prognostic significance of endogenous adhesion\/growth-regulatory lectins in lung cancer","volume":"69","author":"Szoke","year":"2005","journal-title":"Oncology"},{"key":"10.1074\/mcp.M113.030775_bib65","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/JTO.0b013e31824c9272","article-title":"CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions","volume":"7","author":"Blanquart","year":"2012","journal-title":"J. Thorac. Oncol"},{"key":"10.1074\/mcp.M113.030775_bib66","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1074\/jbc.273.19.11429","article-title":"Identification and characterization of a novel human aldose reductase-like gene","volume":"273","author":"Cao","year":"1998","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.M113.030775_bib67","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.510270408","article-title":"New member of aldose reductase family proteins overexpressed in human hepatocellular carcinoma","volume":"27","author":"Scuric","year":"1998","journal-title":"Hepatology"},{"key":"10.1074\/mcp.M113.030775_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2011.05.014","article-title":"AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group","volume":"255","author":"Zhong","year":"2011","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"10.1074\/mcp.M113.030775_bib69","doi-asserted-by":"crossref","first-page":"E862","DOI":"10.1002\/ijc.27618","article-title":"AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker","volume":"131","author":"Ma","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1074\/mcp.M113.030775_bib70","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1158\/1078-0432.CCR-04-1238","article-title":"Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas","volume":"11","author":"Fukumoto","year":"2005","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/mcp.M113.030775_bib71","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2174\/156800909788166538","article-title":"Fibrates in the chemical action of daunorubicin","volume":"9","author":"Balendiran","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1074\/mcp.M113.030775_bib72","first-page":"32","article-title":"The parenteral use of penicillin and streptomycin in complications of distemper","volume":"32","author":"Eads","year":"1951","journal-title":"North Am. Vet"},{"key":"10.1074\/mcp.M113.030775_bib73","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fphar.2012.00005","article-title":"Aldo-keto reductase 1B10 and its role in proliferation capacity of drug-resistant cancers","volume":"3","author":"Matsunaga","year":"2012","journal-title":"Front. Pharmacol"},{"key":"10.1074\/mcp.M113.030775_bib74","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10147-011-0363-7","article-title":"Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer","volume":"18","author":"Hashimoto","year":"2011","journal-title":"Int. J. Clin. Oncol"},{"key":"10.1074\/mcp.M113.030775_bib75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/BJ20111322","article-title":"Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells","volume":"442","author":"Liu","year":"2012","journal-title":"Biochem. J"},{"key":"10.1074\/mcp.M113.030775_bib76","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2407-6-207","article-title":"Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system","volume":"6","author":"Vordermark","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1074\/mcp.M113.030775_bib77","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive strategies that are mediated by tumor cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu. Rev. Immunol"},{"key":"10.1074\/mcp.M113.030775_bib78","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1172\/JCI116755","article-title":"Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques","volume":"92","author":"Giachelli","year":"1993","journal-title":"J. Clin. Invest"},{"key":"10.1074\/mcp.M113.030775_bib79","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1158\/0008-5472.CAN-08-0643","article-title":"Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells","volume":"68","author":"Martin-Manso","year":"2008","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.M113.030775_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1582-4934.2002.tb00307.x","article-title":"Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth","volume":"6","author":"Lawler","year":"2002","journal-title":"J. Cell. Mol. Med"}],"container-title":["Molecular &amp; Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620333855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620333855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.M113.030775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:48:14Z","timestamp":1761526094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620333855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1535947620333855"],"URL":"https:\/\/doi.org\/10.1074\/mcp.m113.030775","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.M113.030775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}